GLP-1 Weight Loss Drugs Reshape Global Healthcare as Demand Surges in 2025-2026
GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing evidence of broader health benefits.